Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The radiotherapy quality assurance gap among phase III cancer clinical trials.
Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. Corrigan KL, et al. Among authors: patel rr. Radiother Oncol. 2022 Jan;166:51-57. doi: 10.1016/j.radonc.2021.11.018. Epub 2021 Nov 25. Radiother Oncol. 2022. PMID: 34838891 Free PMC article. Clinical Trial.
Exclusion of patients with brain metastases from cancer clinical trials.
Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Patel RR, et al. Neuro Oncol. 2020 Apr 15;22(4):577-579. doi: 10.1093/neuonc/noz246. Neuro Oncol. 2020. PMID: 31900480 Free PMC article. No abstract available.
Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
Patel R, Ludmir EB, Miccio JA, Menon H, Barsky AR, Mesko SM, Kodali M, Lautenschlaeger T, Adeberg S, Simone CB 2nd, Verma V. Patel R, et al. Pract Radiat Oncol. 2020 Nov-Dec;10(6):423-433. doi: 10.1016/j.prro.2020.02.007. Epub 2020 Feb 20. Pract Radiat Oncol. 2020. PMID: 32088429 Review.
Corrigendum to "Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy" [Radiother Oncol 150 (2020) 114-120].
Chen D, Patel RR, Verma V, Ramapriyan R, Barsoumian HB, Angelica Cortez M, Welsh JW. Chen D, et al. Among authors: patel rr. Radiother Oncol. 2021 May;158:332-334. doi: 10.1016/j.radonc.2021.01.017. Epub 2021 Mar 10. Radiother Oncol. 2021. PMID: 33714536 No abstract available.
Food and Drug Administration approvals in phase 3 Cancer clinical trials.
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Abi Jaoude J, et al. BMC Cancer. 2021 Jun 12;21(1):695. doi: 10.1186/s12885-021-08457-5. BMC Cancer. 2021. PMID: 34118915 Free PMC article. Clinical Trial.
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial.
Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. Patel RR, et al. Radiother Oncol. 2021 Sep;162:60-67. doi: 10.1016/j.radonc.2021.06.037. Epub 2021 Jul 5. Radiother Oncol. 2021. PMID: 34237343 Clinical Trial.
357 results